글로벌 백내장 치료 시장 - 2029년까지의 산업 동향 및 예측

백내장 치료 시장의 시장 분석 및 통찰력

Data Bridge Market Research는 백내장 치료가 2022-2029년 예측 기간 동안 약 5.00%의 CAGR을 보일 것이라고 분석했습니다. 표적 치료 모드에 대한 수요 증가, 신약 및 치료법 개발을 위한 연구 개발 활동 급증, 전 세계적으로 백내장 관련 질병의 부담을 줄이기 위한 정부 및 비영리 단체의 프로그램 증가, 의료 인프라 개발에 대한 지출 증가가 백내장 치료 시장 성장에 기여하는 주요 요인입니다.

백내장 은 눈과 관련된 장애로, 눈의 수정체가 흐려져 시야가 흐릿해집니다. 백내장은 천천히 시력을 저하시키고 어떤 경우에는 시력을 잃게 만듭니다. 이 의학적 상태에서는 눈의 수정체를 형성하는 단백질이 뭉쳐집니다. 

규제 당국의 특별 지정 증가와 백내장 질환 유병률의 급증은 시장 성장을 촉진하는 주요 요인입니다. 의료 인프라 개발에 대한 지출 증가, 노령 인구 기반 증가, 후진 지역에 대한 인식을 증진하기 위한 정부의 이니셔티브 증가, 시장 참여자 간의 전략적 협력 비율의 급증은 시장 성장을 촉진하는 다른 요인입니다. 당뇨병, 고혈압 및 비만의 유병률 급증은 수익성 있는 시장 성장 기회를 창출할 또 다른 결정 요인입니다.

However, lack of awareness among individuals regarding the benefits of cataract surgery, dearth of skilled medical professionals and unfavourable reimbursement scenario in the developing and under developed economies will pose a major challenge to the market growth. Also, high costs associated with research and development proficiencies and poor healthcare facilities in the underdeveloped economies will further derail the market growth rate. Also, high cost of cataract surgeries will also hamper the market growth rate.

This cataract treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on cataract treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Cataract Treatment Market Scope and Market Size

The cataract treatment market is segmented on the basis of type, treatment, drugs class, drugs, route of administration, distribution channel and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• Based on types, the cataract treatment market is segmented as nuclear cataracts, cortical cataracts, posterior subcapsular cataracts and congenital cataracts.
• Based on treatment, the cataract treatment market is segmented as medication and surgery.
• Based on the drugs class, the cataract treatment market is segmented into mydriatics, antibiotics, ophthalmic NSAIDS, corticosteroids and others.
• Based on the route of administration, the cataract treatment market is segmented into oral and topical.
• Based on the distribution channel, the cataract treatment market is segmented as hospital pharmacy, online pharmacy, retail pharmacy.
• Based on end user, the cataract treatment market is segmented into hospitals, homecare, specialty clinics and others.

Cataract Treatment Market Country Level Analysis

The cataract treatment market is analysed and market size insights and trends are provided by country, type, treatment, drugs class, drugs, route of administration, distribution channel and end user as referenced above.

The countries covered in the cataract treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the cataract treatment market owing to the earliest adoption of innovative technologies, growing research and development capacities and well-structured regulatory framework. Asia-Pacific is projected to undergo substantial gains during the forecast period and score the highest CAGR. This is because of the rising expenditure to develop healthcare infrastructure, increasing health care spending, rising prevalence of cataract disorders, favourable regulations and increasing personal disposable income.

The country section of the cataract treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The cataract treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the cataract treatment market in the growth period.

Competitive Landscape and Cataract Treatment Market Share Analysis

백내장 치료 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 위에 제공된 데이터 포인트는 백내장 치료 시장과 관련된 회사의 초점에만 관련이 있습니다.

백내장 치료 시장 보고서에서 활동하는 주요 기업으로는 Abbott, Johnson & Johnson Services, Inc, Novartis AG, HOYA Corporation, Carl-Zeiss-Stiftung, Alcon Vision LLC, Essilor, Ziemer Ophthalmic Systems, Bausch Health, GENZUM LIFE SCIENCES, AbbVie Inc, Santen Pharmaceutical Co., Ltd, Omeros Corporation, Sun Pharmaceutical Industries Ltd, EyePoint Pharmaceuticals, Inc., Reata Pharmaceuticals, Inc., Acumen BioPharma, LLC, Takeda Pharmaceutical Company Limited, AstraZeneca 및 F. Hoffmann-La Roche Ltd 등이 있습니다.

SKU-50473